the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study
Launched by HORSENS HOSPITAL · Aug 26, 2021
Trial Information
Current as of May 28, 2025
Unknown status
Keywords
ClinConnect Summary
The aim of this study is to investigate the feasibility of a 12-weeks (progressive) exercise program in patients with FAIS. Feasibility is evaluated on the recruitment strategy, patient adherence to the exercises and their experiences with and motivation for performing exercises. Furthermore, the investigators wish to investigate the variation of data before and after the exercise program to help estimate a suitable sample size for a future randomized controlled trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients aged 18-50 years old
- • 2. Diagnosed with FAIS according to the Warwick agreement
- • 3. Patients having cam morphology should have an alpha angle of \> 55 degrees on an anterior-posterior radiograph.
- • 4. Patients having pincer should have a lateral centre edge angle of \>39 degrees on an anterior-posterior radiograph.
- • 5. Lateral joint space width should be \>3 mm.
- • 6. Body mass index is below 30.
- • 7. Motivated for participation in a 12 week training program with 8 physical attendances.
- Exclusion Criteria:
- • 1. Received physiotherapist-led treatment in the past 3 months,
- • 2. Previous hip surgery in included hip or other major hip injury,
- • 3. Systemic conditions e.g. rheumatoid arthritis, cancer,
- • 4. Chronical pain syndromes,
- • 5. Unable to perform testing procedures,
- • 6. Unable to attend a 12-week treatment program or baseline and follow-up assessments
- • 7. Contraindications to radiographs (e.g. pregnancy)
- • 8. Unable to read or understand questionnaires and/or instructions
About Horsens Hospital
Horsens Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, the hospital leverages its state-of-the-art facilities and a team of experienced healthcare professionals to conduct rigorous studies across various medical fields. Committed to ethical standards and patient safety, Horsens Hospital strives to contribute valuable insights to the scientific community and enhance treatment options for patients. Through its robust clinical trial program, the hospital plays a pivotal role in translating research findings into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Signe Kierkegaard, PhD
Principal Investigator
Regionshospitalet Horsens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials